Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. | 489,111 | reported | 23 Jun 2023 | tx 30+808,300−53,700 |
| Lineage Cell Therapeutics, Inc. | 50,000 | reported | 01 Jul 2023 | tx 110+7,556,331−8,729,689 |
| Asterias Biotherapeutics, Inc. | 9,000 | reported | 09 Jun 2016 | tx 5+179,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jul 2023 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 20,000 | 0.00 USD | |
| 23 Jun 2023 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 90,000 | 0.00 USD | deriv |
| 14 Jun 2023 | PURCHASE | Insight Molecular Diagnostics Inc. | 30,000 | 0.21 USD | |
| 01 Dec 2022 | GIFT | Lineage Cell Therapeutics, Inc. | 25,000 | — | |
| 22 Dec 2022 | PURCHASE | Insight Molecular Diagnostics Inc. | 25,000 | 0.29 USD | |
| 15 Aug 2022 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 10,000 | 0.00 USD | |
| 15 Aug 2022 | PURCHASE | Insight Molecular Diagnostics Inc. | 5,000 | 0.97 USD | |
| 15 Aug 2022 | PURCHASE | Insight Molecular Diagnostics Inc. | 5,000 | 0.97 USD | first after silence |
| 15 Aug 2022 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 45,000 | 0.00 USD | deriv |
| 24 Jun 2022 | EXERCISE | Insight Molecular Diagnostics Inc. | 10,000 | 0.00 USD | |
| 24 Jun 2022 | EXERCISE | Insight Molecular Diagnostics Inc. | 10,000 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 01 Dec 2021 | GIFT | Lineage Cell Therapeutics, Inc. | 14,700 | — | |
| 01 Jul 2021 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 10,000 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 45,000 | 0.00 USD | deriv |
| 22 Jun 2021 | EXERCISE | Lineage Cell Therapeutics, Inc. | 61,800 | 2.20 USD | |
| 22 Jun 2021 | EXERCISE | Lineage Cell Therapeutics, Inc. | 61,800 | 0.00 USD | deriv |
| 01 Dec 2020 | GIFT | Lineage Cell Therapeutics, Inc. | 17,500 | — | |
| 28 Dec 2020 | EXERCISE | Insight Molecular Diagnostics Inc. | 65,271 | 1.34 USD | |
| 23 Dec 2020 | SALE | Insight Molecular Diagnostics Inc. | 900 | 2.55 USD | |
| 23 Dec 2020 | EXERCISE | Insight Molecular Diagnostics Inc. | 1,237 | 1.34 USD | |
| 28 Dec 2020 | EXERCISE | Insight Molecular Diagnostics Inc. | 65,271 | 1.34 USD | deriv |
| 23 Dec 2020 | EXERCISE | Insight Molecular Diagnostics Inc. | 1,237 | 1.34 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 15 Aug 2022.